Our company news

Smooth initiates a phase II trial in patients with chronic HDV

Published on Friday February 05, 2016

Smooth Drug Development initiates a new phase II clinical trial in patients with chronic HDV in Russia.

Read more →

Smooth initiates a phase III trial in non-alcoholic fatty liver disease

Published on Friday February 05, 2016

Smooth Drug Development initiates a new phase III trial in patients with non-alcoholic fatty liver disease and metabolic syndrome.

Read more →

Smooth Drug Development summarizes results of 2015

Published on Monday December 28, 2015

Smooth Drug Development summarizes results of 2015. Fast facts: confirmed ISO 9001:2008, 40+ trials completed, 100+ sites initiated, 1000+ patients enrolled.

Read more →

We wish you Merry Christmas and Happy New Year!

Published on Monday December 21, 2015

Smooth Drug Development wishes you a Merry Christmas and a Happy New Year!

Read more →

Smooth conducted a Round table on Multiple Sclerosis in Moscow

Published on Monday October 26, 2015

Successfully in Moscow held a Round table: The Algorithm of choice of therapy and the risk management plan at treatment with second-line drugs for patients with MS.

Read more →

Round table on Multiple Sclerosis will be held in Moscow

Published on Thursday October 22, 2015

In Moscow 25 October will be held a Round table: The Algorithm of choice of therapy and the risk management plan at treatment with second-line drugs for patients with MS.

Read more →

Smooth Drug Development has moved to a new office building

Published on Monday October 12, 2015

We would like to inform, that Smooth Drug Development moved into a new office building in connection with the staff increase.

Read more →

Smooth Drug Development is initiating an international phase II study in HDV

Published on Monday July 27, 2015

Smooth Drug Development is initiating an international phase II study in Hepatitis D virus.

Read more →

Smooth opens an office in Moscow

Published on Monday June 15, 2015

Smooth Drug Development is pleased to announce opening of the Moscow representative office located at build.1, 12/19, Verkhnaya Radishchevskaya, Moscow, Russia, 109240, Taganskaya metro station.

Read more →

Smooth successfully passed the quality audit by Sandoz, a Novartis company

Published on Sunday June 14, 2015

Smooth Drug Development proudly announces successful completion of the selection quality audit performed by Sandoz, a Novartis company.

Read more →

We attend BIO International Convention June 15-18, 2015 in Philadelphia

Published on Monday June 08, 2015

Smooth Drug Development will take part in the worlds largest conference of the biotechnology – BIO International Convention 2015.

Read more →

Smooth Drug Development obtained ISO 9001:2008 certificate

Published on Friday January 16, 2015

Smooth Drug Development has obtained ISO 9001:2008 certification, validating the process approach for management of clinical trials.

Read more →

Smooth Drug Development has conducted a GCP training for investigators

Published on Monday November 17, 2014

Smooth Drug Development has conducted a GCP training for investigators.

Read more →

Smooth has conducted an Investigator’s Meeting in Moscow

Published on Tuesday November 11, 2014

Smooth Drug Development has conducted an Investigator’s Meeting in Moscow.

Read more →

Smooth Drug Development attends Innovative Drug Research & Development Forum

Published on Monday November 10, 2014

Smooth Drug Development attends Innovative Drug Research & Development Forum.

Read more →